RVTY - Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes
RVTY - Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes
Revvity, Inc. (NYSE: RVTY) today announced the launch of the GSP® T1D 3plex kit, a fully automated, CE-IVDR-certified, multiplex autoantibody (AAb) detection solution to enable population-wide screening programs that identify children at risk of developing type 1 diabetes (T1D) before symptoms appe…